TY - JOUR
T1 - “Drug Use with Racism…The Reason I Wanted to Do This Study”
T2 - Perceptions of Race and Racism’s Impact on Drug Use among Black Americans Using Opioids
AU - Malone, Natalie
AU - Pitcher, Gabriella R.
AU - Mizelle, Destin L.
AU - Wheeler, Paris
AU - Miller-Roenigk, Brittany
AU - McCleod, Kendall A.
AU - Keeling, Mekaila
AU - Ntego, Tristan
AU - Hargons, Candice N
AU - Stevens-Watkins, Danelle
N1 - Publisher Copyright:
© 2024 Taylor & Francis Group, LLC.
PY - 2025
Y1 - 2025
N2 - Background: Several studies link racism with drug use disparities among systemically marginalized populations. However, few invite Black Americans to discuss how they perceive racism’s impact on their drug use. Objectives: To examine qualitative accounts from N=40 Black adults reporting non-medical prescription opioid use on their experiences of racism and drug use. Results: A deductive structural tabular thematic analysis informed by Jones’s (2000) levels of racism resulted in two themes: (a) Experiences of Racism (subthemes: Denying Experiences of Racism and Endorsing Experiences of Racism) and (b) Race, Racism, and Drug Use (subthemes: Rejecting Race and Racism’s Impact on Drugs and Rejecting Race and Racism’s Impact on Drugs). Conclusions: Participants provided examples of internalized, personally mediated, and institutionalized racism associated with their drug use. Implications for policy, practice, and research are discussed. Specifically, implications detail how to center Black Americans and demonstrate anti-racism when developing treatment strategies and drug policies.
AB - Background: Several studies link racism with drug use disparities among systemically marginalized populations. However, few invite Black Americans to discuss how they perceive racism’s impact on their drug use. Objectives: To examine qualitative accounts from N=40 Black adults reporting non-medical prescription opioid use on their experiences of racism and drug use. Results: A deductive structural tabular thematic analysis informed by Jones’s (2000) levels of racism resulted in two themes: (a) Experiences of Racism (subthemes: Denying Experiences of Racism and Endorsing Experiences of Racism) and (b) Race, Racism, and Drug Use (subthemes: Rejecting Race and Racism’s Impact on Drugs and Rejecting Race and Racism’s Impact on Drugs). Conclusions: Participants provided examples of internalized, personally mediated, and institutionalized racism associated with their drug use. Implications for policy, practice, and research are discussed. Specifically, implications detail how to center Black Americans and demonstrate anti-racism when developing treatment strategies and drug policies.
KW - Black adults
KW - opioids
KW - race/ethnicity
KW - racism
UR - http://www.scopus.com/inward/record.url?scp=85209930911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85209930911&partnerID=8YFLogxK
U2 - 10.1080/10826084.2024.2423371
DO - 10.1080/10826084.2024.2423371
M3 - Article
C2 - 39506268
AN - SCOPUS:85209930911
SN - 1082-6084
VL - 60
SP - 265
EP - 275
JO - Substance Use and Misuse
JF - Substance Use and Misuse
IS - 2
ER -